Prevencion secundaria del ictus isquémico. Efecto de la dosis en el perfîl de la aspirina

Revista de Neurologia

Volumn 25, Issue 140, 1997, Pages 541-544

  Alvarcz Sabin J ^a,b   Calvo, G ^a   Morros, R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Serviciodeneiirologiahospitalgeneraliuniversitarivalld'Hebron   (Spain)

Author keywords

Dose of aspirin; Intracerebral hemorrhage; Isch mie stroke; Platelet antiaggregation; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; PLACEBO;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; RANDOMIZED CONTROLLED TRIAL; GASTROINTESTINAL HEMORRHAGE; MAJOR CLINICAL STUDY; PEPTIC ULCER; SECONDARY PREVENTION; STROKE;

ASPIRIN; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PLACEBOS; PLATELET AGGREGATION INHIBITORS;

EID: 0031011512     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Antiplatelet Trialist's Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients., BMJ 1994; 308: 81-106.
2. Alvarez Sabin J. Acido actilsalicilico y triflusal en la prevencion del infarto cerebral aterotrombötico. Rev Neurol 1995; 23: 1091-1095.
3. Matchar D, Duke University, pers. commun. Citado en Barnett HJM. Drug and surgical issues in stroke prevention. Cerbrovasc Dis 1994; 4 (SuppI 1): 16-25.
4. UK-TIA Study Group. United Kingdom transient ischaemic attack (UKTIA) aspirin trial: interim results. BMJ 1988; 296: 316-320.
5. UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final reports. J Neurol Neurosurg Psychiatry 1991; 54: 1044-1054.
6. Petersen P, Godtfredsen J, Boysen G, et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989; 1: 175-179.
7. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990; 322: 863-868.
8. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991; 84: 527-539.
9. The Ducht TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischémie attack or minor ischémie stroke. N Engl J Med 1991 ; 325: 1261 -1266.
10. The SALT Collaborative Group. Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cere-brovascular ischaemic events. Lancet 1991; 338: 1345-1349.
11. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255-1262.
12. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687-691.
13. Matias-Guiu J, Alvarez Sabin J, Galiano L, Codina A. The efficacy and safety of low-dose aspirin versus triflusal in the long-term outcome of young stroke patients. Neurolosy 1994; 44 (Suppl 2): A288.
14. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301-315.
15. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Part II: surgical group. Stroke 1978; 9: 309-319.
16. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299; 53-59.
17. Candelise L, Land! G, Perrone P, et al. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke 1982; 13: 175-179.
18. Bousser MG, Eschwegw E, Haguenau M, et al. 'AICLA controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke 1983; 14: 5-14.
19. Sorensen PS, Pedersen H, Marquardsen J, et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischémie attacks. A Danish cooperative study. Stroke 1983; 14: 15-22.
20. Garde A, Samuelsson K, Fahlgren H, et al. Treatment after transient ischémie attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation. Stroke 1983; 14:677-681.
21. The American-Canadian Cooperative Study Group. Persantine Aspirin Trial in cerebral ischemia. Part II: endpoint results. Stroke 1985; 16: 406-415.
22. A Swedish Cooperative Study. High-dose acetylsalicylic acid after cerebral infarction. Stroke 1987; 18: 325-334.
23. Hass VK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501-507.
24. Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmac 1991; 32: 77-83.
25. Fuster V, Dyken ML, Vokonas PS, Hennekens Ch. Aspirin as a therapeutic agent in cardiovascular disease (Special report). Circulation 1993; 87: 659-675.
26. Prichard PJ, Kitchingman GK, Walt RP, et al. Human gastric mucosal bleeding induced by low dose aspirine, but not warfarin. BMJ 1989; 298: 493-496.
27. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830.
28. Steering Committee of the Physician's Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoind physician's health study. N Engl J Med 1988; 318:262-264.
29. Steering Committee of the Physician's Health Study Research Group. Final report on the aspirin component of the ongoind physician's health study. N Engl J Med 1989; 321: 129-135.
30. Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ 1988; 296: 313-316.